Kss Medicalcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 M
as on 23-10-2024
- Satisfied Charges ₹ 18.23 Cr
as on 23-10-2024
- Revenue -68.58%
(FY 2023)
- Profit 2706.94%
(FY 2023)
- Ebitda -77.03%
(FY 2023)
- Net Worth 47.75%
(FY 2023)
- Total Assets -39.69%
(FY 2023)
About Kss Medicalcare
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 M. The company has closed loans amounting to ₹18.23 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bimla Surjewala and Supreet Surjewala serve as directors at the Company.
- CIN/LLPIN
U24304DL2018PTC339540
- Company No.
339540
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Sep 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kss Medicalcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bimla Surjewala  | Director | 24-Apr-2023 | Current |
| Supreet Surjewala | Director | 27-Sep-2018 | Current |
Financial Performance of Kss Medicalcare.
Kss Medicalcare Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 68.58% decrease. The company also saw a substantial improvement in profitability, with a 2706.94% increase in profit. The company's net worth Soared by an impressive increase of 47.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kss Medicalcare?
In 2023, Kss Medicalcare had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Kss Progressive Capital Private LimitedActive 6 years 9 months
Bimla Surjewala and Supreet Surjewala are mutual person
- S Three H Infrastructure Development Private LimitedActive 17 years 4 months
Supreet Surjewala is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 24 Aug 2021 | ₹2.50 M | Open |
Others Creation Date: 29 Jul 2021 | ₹4.49 Cr | Satisfied |
Others Creation Date: 30 Dec 2019 | ₹4.10 M | Satisfied |
How Many Employees Work at Kss Medicalcare?
Unlock and access historical data on people associated with Kss Medicalcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kss Medicalcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kss Medicalcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
